News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Continue Reading Previous Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories Cancer Clinical Trial Coronavirus COVID-19 News Pharmaceutical Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference Staff March 18, 2024 News Pharmaceutical BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps Staff March 18, 2024 Clinical Trial Healthcare News Unique Treatment for BPH, Chronic Prostatitis, Back Pain and Kidney Stones Was Unveiled at Arab Health 2024 by Ariana Adjani Staff March 17, 2024